B. Ferslew

发表

Drug Transport in the Liver

K. Brouwer, K. Köck, B. Ferslew, 2014 .

Risk Factors for Development of Cholestatic Drug-Induced Liver Injury: Inhibition of Hepatic Basolateral Bile Acid Transporters Multidrug Resistance-Associated Proteins 3 and 4

K. Brouwer, P. Swaan, T. Urban, 2014, Drug Metabolism and Disposition.

Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis.

K. Brouwer, D. Zeldin, M. Edin, 2016, Prostaglandins & other lipid mediators.

Role of Multidrug Resistance–Associated Protein 4 in the Basolateral Efflux of Hepatically Derived Enalaprilat

K. Brouwer, Arlene S. Bridges, B. Ferslew, 2014, Drug Metabolism and Disposition.

Identification of hepatic phospholipidosis inducers in sandwich-cultured rat hepatocytes, a physiologically relevant model, reveals altered basolateral uptake and biliary excretion of anionic probe substrates.

K. Brouwer, B. Ferslew, 2014, Toxicological sciences : an official journal of the Society of Toxicology.

DMD057554 1567..1574

K. Brouwer, Arlene S. Bridges, B. Ferslew, 2014 .

Special Section on Transporters in Toxicity and Disease Risk Factors for Development of Cholestatic Drug-Induced Liver Injury: Inhibition of Hepatic Basolateral Bile Acid Transporters Multidrug Resistance-Associated Proteins 3 and 4

K. Brouwer, P. Swaan, T. Urban, 2014 .

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

K. Brouwer, G. Xie, W. Jia, 2015, Digestive Diseases and Sciences.

Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP)

K. Brouwer, R. Hardwick, Yang Lu, 2016 .

Homicidal poisoning deaths in the United States 1999–2005

G. Shepherd, B. Ferslew, 2009, Clinical toxicology.

Key Role for the 12-Hydroxy Group in the Negative Ion Fragmentation of Unconjugated C24 Bile Acids.

K. Brouwer, Wei Jia, G. Xie, 2016, Analytical chemistry.

Hepatic Basolateral Efflux Contributes Significantly to Rosuvastatin Disposition II: Characterization of Hepatic Elimination by Basolateral, Biliary, and Metabolic Clearance Pathways in Rat Isolated Perfused Liver

K. Brouwer, R. Hardwick, Arlene S. Bridges, 2013, The Journal of Pharmacology and Experimental Therapeutics.

In Vitro Characterization of Intestinal and Hepatic Transporters: MRP2

D. Thakker, S. Dallas, J. Kunta, 2014 .

Importance of Hepatic Transporters, Including Basolateral Efflux Proteins, in Drug Disposition: Impact of Phospholipidosis and Non-Alcoholic Steatohepatitis

B. Ferslew, 2014 .

P469 Safety, tolerability, and pharmacokinetics of the intestine-restricted oral pan-Janus kinase inhibitor TD-1473 after single and multiple oral doses in healthy subjects.

D. Nguyen, C. Sherman, R. Graham, 2017, Journal of Crohn's & colitis.

Risk Factors for Development of Cholestatic Drug-Induced Liver Injury: Inhibition of Hepatic Basolateral Bile Acid Transporters Multidrug Resistance-Associated Proteins 3 and 4

K. Brouwer, P. Swaan, T. Urban, 2014, Drug Metabolism and Disposition.